intrauterine use of 18-methyl-15ß, 16ß-methylene-19-nor-20-spirox-4-en-3-ones, intrauterine systems containing 18-methyl-15ß, 16ß-methylene-19-nor-20-spirox 4-en-3-ones, as well as their use in contraception and gynecological treatment
HARRI JUKARAINEN,HENRIIKKA KOROLAINEN,KATJA PRELLE,LARS RÖSE,NORBERT SCHMEES,REINHARD NUBBEMEYER,TUULA VALO
申请号：
BR112014026193
公开号：
BR112014026193A2
申请日:
2013.04.19
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
Patent Summary: "intrauterine use of 18-methyl-15ß, 16ß-methylene-19-nor-20-spirox-4-en-3-ones, intrauterine systems containing 18-methyl-15ß, 16ß-methylene-19- nor-20-spirox-4-en-3-ones, as well as their use in contraception and gynecological treatment. " The present invention relates to the intrauterine application of 18-methyl-15ß, 16ß-methylen-19-nor-20-spirox-4-en-3-ones of the general formula (1) (1) in contraception and gynecological therapy. as well as an intrauterine system containing compounds of formula (1).resumo patente de invenção: "uso intrauterino de 18-metil-15ß,16ß-metileno-19-nor-20-espirox-4-en-3-onas, sistemas intrauterinos contendo 18-metil-15ß,16ß-metileno-19-nor-20-espirox-4-en-3-onas, bem como o uso dos mesmos na contracepção e no tratamento ginecológico". a presente invenção refere-se à aplicação intrauterina de 18-metil-15ß,16ß-metilen-19-nor-20-espirox-4-en-3-onas da fórmula geral (1) (1) na contracepção e na terapia ginecológica, bem como um sistema intrauterino contendo compostos da fórmula (1).
